Molecular response to treatment in childhood acute lymphoblastic leukemia (ALL). Shown are percentages of patients enrolled in Total XIII, XIV and XV Studies at St Jude Children’s Research Hospital who were MRD-negative (< 0.01% leukemic cells in bone marrow) at sequential treatment intervals.